Understanding Dideoxy Sequencing: The Foundation of Modern Genomics

Introduction — Why Dideoxy Sequencing Still Matters

Before the advent of high-throughput genomics, a deceptively simple trick unlocked the secrets of DNA. The dideoxy or "chain-termination" sequencing method, first published in 1977, laid the biochemical foundation for modern genomics. (Sanger, Nicklen & Coulson, 1977. DOI: 10.1073/pnas.74.12.5463)

At first glance, chain termination seems almost too elegant to be true: incorporate a modified nucleotide lacking a 3′ hydroxyl, stop the reaction, read fragment lengths—and deduce the sequence. Yet this innovation catalysed the rapid scaling of genomics, from small plasmids to full genomes. In many labs today, dideoxy sequencing still serves as the "ground truth" validation method for variant calls and amplicons.

In this article, we'll:

• Explain in biochemical detail how chain-termination (dideoxy) sequencing works.
• Show the conceptual thread connecting that method to modern NGS platforms.
• Highlight why understanding this "classic" method remains essential for interpreting high-throughput sequencing results.

Through this narrative, we aim not only to teach the science but also to build credibility—with you, the researcher, as our peer. Let's begin by exploring how dideoxy sequencing diverged from earlier sequencing strategies and why it was revolutionary.

What Is Dideoxy Sequencing and Why It Was Revolutionary

Defining Dideoxy (Chain-Termination) Sequencing

Long before next-generation platforms, researchers faced a key challenge: how to read each base of DNA accurately, one by one. The dideoxy (chain-termination) sequencing method solved that elegantly.

In dideoxy sequencing, you set up a DNA synthesis reaction containing:

• A single-stranded DNA template
• A primer that hybridizes to the template
• DNA polymerase
• Normal deoxynucleotides (dNTPs)
• A small proportion of dideoxynucleotides (ddNTPs)

Because ddNTPs lack the 3′-OH group, once they are added, the polymerase cannot elongate further. Over many parallel reactions, this yields a nested set of fragments, each ending at every possible position along the template. By separating these fragments by size, and detecting the terminal label, you can deduce the original sequence base by base.

Why Dideoxy Sequencing Was a Breakthrough

Clarity and Read Length

Earlier chemical sequencing methods were laborious and error-prone. The chain-termination trick produced clearer, more interpretable data with longer effective read lengths. It became possible to sequence entire genes and small viral genomes.

Simplicity That Enabled Automation

The core concept—"stop when a ddNTP is inserted"—is conceptually simple. This simplicity allowed researchers to move from gel-based manual methods to automated capillary systems over time.

A New Benchmark of Accuracy

In favorable conditions, Sanger sequencing achieves extremely low error rates, making it a reliable validation tool. Even with today's high-throughput platforms, many labs retain dideoxy sequencing as the "gold standard" for confirming critical variants.

In practice, dideoxy sequencing became ubiquitous in molecular biology labs. Over decades, it enabled sequencing of plasmids, bacterial chromosomes, and viral genomes—essential steps leading up to large projects like the Human Genome Project .

The Biochemistry Behind Chain Termination

At the heart of dideoxy sequencing lies a deceptively simple chemical trick: inserting a "broken" nucleotide that halts synthesis. Understanding this mechanism helps explain why the method is so precise—and why its logic persists even in modern NGS platforms.

Core Principle: Missing the 3′-OH

Normal deoxynucleotides (dNTPs) carry a hydroxyl (–OH) group at the 3′ carbon of the sugar. DNA polymerases rely on that group to form a phosphodiester bond with the next nucleotide's 5′ phosphate.

Dideoxynucleotides (ddNTPs) are structurally identical except that they lack the 3′-OH group. Without that hydroxyl, no further extension is possible after incorporation.

When ddNTP is randomly incorporated into the growing strand, chain elongation stops decisively at that point—hence "chain termination." This single molecular modification is what gives the method its power.

Balancing Incorporation: dNTP vs. ddNTP

Because ddNTPs stop extension, they must be present only in low, controlled proportions relative to dNTPs. If ddNTPs were too abundant, most chains would terminate prematurely; if too scarce, many positions would never be represented. Typical reaction designs use ddNTP:dNTP ratios that optimize random termination across the sequence.

This probabilistic balance ensures that across many molecules, every possible termination point is sampled.

Polymerase Behavior and Discrimination

DNA polymerases naturally prefer "normal" dNTPs over ddNTPs. This discrimination requires careful tuning of the reaction. (Sequenase modifications, T7 polymerase discrimination)

Some specialized polymerases (or engineered variants, like Sequenase) reduce discrimination against ddNTPs, thereby enabling more even termination probability and cleaner fragment distributions. (T7 polymerase / Sequenase)

In practice, polymerase choice, salt conditions, and nucleotide concentrations are all optimized for uniform termination across the template.

Generation of the Fragment Ladder

Over many parallel copies:

• Each template strand is primed and extended.
• Occasionally, a ddNTP is incorporated, halting that strand.
• Because of statistical distribution, fragment sizes terminate at every possible base along the template.
• That produces a "ladder" of fragments that differ by single nucleotide length increments. (Chain termination description)
• When you resolve those fragments by size (via electrophoresis), the identity of the terminal ddNTP (via label) reveals which base was at each position.

Fluorescent Labeling & Detection

To convert termination events into readable signals:

• Each ddNTP is often tagged with a distinct fluorescent dye.
• When fragments pass through a detector (e.g. capillary electrophoresis), the fluorescent emission at each band indicates whether the terminating base was A, T, C or G.
• This allows automated base-calling rather than manual reading.

This dye-labeling strategy is the bridge point to modern sequencing—as many NGS methods still rely on terminator-type chemistry with optical detection.

How Dideoxy Sequencing Shaped Modern NGS Platforms

Even though dideoxy sequencing (Sanger) is now largely superseded in throughput, its core chemical insight—controlled nucleotide termination—lives on in many next-generation sequencing systems. In this section, we explore how the logic of chain termination evolved into the reversible-terminator chemistry used in platforms like Illumina, and why that continuity matters for users and analysts.

The Conceptual Bridge: Irreversible → Reversible Termination

• In Sanger sequencing, incorporation of a ddNTP irreversibly halts strand synthesis.
• NGS platforms like Illumina adopted a more subtle twist: reversible terminators. These modified nucleotides temporarily block extension, allow imaging, then get unblocked to permit the next cycle. (Rodriguez & Krishnan, Nature Biotechnology, 2023)
• Thus, rather than a one-time stop, synthesis is paused, read, then resumed in a controlled, cyclic fashion.

This adaptation preserves the idea of "stop-and-read," but recycles it multiple times for each molecule, enabling massively parallel sequencing.

Reversible Terminator Chemistry in Illumina SBS

Illumina's sequencing-by-synthesis (SBS) method is the archetype of how dideoxy principles were expanded for high throughput. Key features:

• Each cycle introduces a mixture of four fluorescently labeled, reversibly terminating nucleotides.
• After one base is incorporated, imaging is performed to record the fluorescent signal.
• A cleavage step removes the fluorescent tag and the blocking moiety, restoring the 3′-OH and allowing the next base to be added.
• Because each molecule undergoes repeated cycles of termination → imaging → de-blocking, the method enables reading dozens to hundreds of bases per template. (Nature perspective)

One useful way to see the lineage:

• Sanger uses permanent chain termination (ddNTP) → one read per reaction per fragment.
• Illumina uses reversible termination → multiple reads per fragment, leveraging imaging cycles.

Figure 1 Schematic showing sequencing during synthesis using 3′-O blocking reversible terminators

Engineering Challenges and Innovations

Bringing termination chemistry into the NGS world required overcoming several biochemical hurdles:

Designing suitable terminator nucleotides

The blocking group must inhibit further extension, but also be removable without damaging the strand or introducing bias.

Polymerase compatibility

Standard DNA polymerases strongly discriminate against modified nucleotides. Engineers had to evolve or engineer polymerases that accept terminator nucleotides with high fidelity. (Rodriguez & Krishnan, 2023),

Error correction and signal fidelity

Optical imaging, incomplete cleavage, or carry-over signal "scars" can degrade accuracy. Strategies to minimize these artifacts were crucial for reliable base calling.

Throughput scaling

Sanger sequencing required physical separation of fragments on gels or capillaries. Illumina and related systems developed dense surface chemistry (flow cells), cluster amplification, and parallel optics.

Thus, although the execution differs radically, the conceptual backbone of chain termination remains a guiding principle.

Why This Evolution Matters to You

Understanding this chemical lineage isn't just academic—it offers several practical insights:

Error modes: Knowing that modern NGS relies on terminator cleavage and re-initiation helps one interpret systematic biases or signal decay in homopolymer or GC-rich regions.

Quality validation: Labs still use Sanger (dideoxy) sequencing as a gold-standard check. Understanding the shared logic helps make deeper comparisons.

Method selection: For small amplicons or critical validation, dideoxy sequencing may remain optimal. For large-scale projects, reversible-terminator platforms are the scalable extension of chain-termination logic.

Advantages and Limitations of Dideoxy Sequencing

Dideoxy sequencing (Sanger method) remains respected for certain strengths, but it also comes with clear trade-offs. Understanding both sides helps you pick the right tool for your sequencing needs.

Key Advantages

Exceptional Base Accuracy

Because each base call comes from a single, clean termination event with minimal background noise, Sanger sequencing routinely achieves error rates below 0.001% (i.e. >99.999% accuracy) under ideal conditions.

This high fidelity makes it a trusted "ground truth" for validating variant calls generated by higher-throughput platforms (NGS).

Relatively Long Read Lengths

With well-optimized chemistry and high-quality templates, read lengths of 600–800 bases (and occasionally up to ~1,000 bases) are attainable on modern capillary systems. (RTSF "Best Practices" guide)

These longer contiguous reads reduce ambiguous base calls over moderately sized regions and simplify interpretation of indels or small structural changes.

Simple Data Interpretation & Lower Bioinformatics Overhead

The output is usually a single chromatogram per reaction, which is straightforward to inspect, manually correct, or integrate with existing pipelines.

You avoid the heavy compute burden of de novo assembly or read mapping that often comes with NGS datasets.

Versatility & Established Workflows

Dideoxy sequencing works well on plasmids, PCR amplicons, cloned inserts, and shorter genomic fragments.

Because it's mature technology, many labs already have the instrumentation, protocols, and hands-on experience.

Cost-Effectiveness at Small Scale

For a few samples or targeted regions, Sanger sequencing remains economical compared to preparing a full NGS run. You don't pay for wasted capacity.

It's a practical solution for variant confirmation, clone verification, or small panels.

Important Limitations to Know

Low Throughput & Poor Scalability

The biggest drawback is its inefficient scaling. Each reaction sequences one template; to cover large gene panels, exomes, or whole genomes, the cost and labor skyrocket.

For population-level or large-scale discovery, NGS is vastly more economical per base.

Upper Read Limit Constraints

While 600–800 bp is common, beyond that, signal noise, dye artifacts, and electrophoretic resolution degrade quality. Typical Sanger systems struggle after ~900 bp.

This limits usefulness for long repetitive or highly structured DNA segments.

Limited Sensitivity for Low-Frequency Variants

Because Sanger reads are ensemble averages of many molecules, variants present at <15–20% allele frequency are often invisible or ambiguous.

It's not ideal for detecting rare somatic mutations or mosaicism in mixed populations.

Cost Per Base Is High at Larger Scale

Once you scale to dozens or hundreds of targets, reagent and labor costs per base become less competitive compared to NGS bulk pricing.

Sensitivity to Template Quality and Reaction Conditions

Impurities, secondary structure, or suboptimal primer/template stoichiometry can compromise read quality. Because there is no amplification buffering (beyond PCR prep), any flaw often shows in the final trace.

Limited Capacity for Complex Variants & Structural Elements

Large structural variants (e.g. copy-number changes, inversions) or long tandem repeats exceed what a single Sanger read can resolve.

Also, highly GC-rich or repetitive sequences can stall extension or produce ambiguous reads.

When Dideoxy Sequencing Still Wins

Despite these limitations, Sanger sequencing is still the right choice when:

• You only need to sequence a few targeted loci or confirm specific variants
• Read length of 500–800 bp suffices
• You require the highest base accuracy (e.g. for plasmid validation or cloning)
• You have limited access to high-throughput platforms or want to avoid library prep overhead

By contrast, NGS becomes preferable when sample throughput, comprehensive coverage, or variant discovery scale are priorities.

From Classic Capillaries to Modern Automation

The transition from slab gels to capillary electrophoresis (CE) marked a pivotal shift—turning labor-intensive sequencing into a high-throughput, automated workflow. Modern Sanger sequencing instruments integrate reaction, separation, detection, and data processing with minimal hands-on labor.

Why Capillaries Replaced Slab Gels

Slab gel electrophoresis (polyacrylamide gels) was the early standard for resolving dideoxy-terminated fragments. However:

• Gel casting, loading, and handling are laborious and error-prone.
• Heat dissipation and diffusion limit resolution in long gels.
• Throughput is constrained by the physical lanes available.

Capillary electrophoresis addressed these issues:

• Smaller scale & better heat control: narrow capillaries dissipate heat more efficiently, allowing higher voltages and faster runs. (Capillary electrophoresis advantages)
• Automated injection & detection: samples are loaded electrokinetically or via pressure, and separation proceeds without manual gel handling.
• Higher resolution & reproducibility: single-base resolution over longer stretches is maintained more reliably in capillaries.
• Multiplexing via capillary arrays: instruments with many parallel capillaries enable moderate to high sample throughput.

Thermo Fisher's applied-biosystems manuals detail how capillary systems form the backbone of automated Sanger workflows.

Key Components of Automated Capillary Sanger Systems

Modern DNA sequencers integrate multiple steps with precise control. Core components include:

Reaction module (cycle sequencing + cleanup):

The dideoxy extension reaction and cleanup (e.g. removing unincorporated dyes, salts) are often robotically handled or pre-prepared before entering the capillary module.

Capillary separation array:

Each capillary is filled with a sieving polymer (e.g. linear polyacrylamide) to separate DNA fragments by length. Capillaries are often arranged in arrays (e.g. 16, 48, 96) for parallel processing.

Optical detection window and laser/CCD systems:

As fluorescently labeled fragments migrate past a detection window, a laser excites the dye and the emitted fluorescence is captured and spectral-separated.

Signal processing and base calling software:

Raw fluorescence traces are translated into chromatograms (electropherograms). Peaks are assigned to bases and quality scores. In advanced labs, tools like HiTRACE (High-Throughput Robust Analysis of Capillary Electrophoresis) further automate alignment, band annotation, and trace quantification. (Yoon et al., 2011)

Automated sample handling and robotics:

Instruments may include plate stackers, barcode readers, automated polymer delivery, and remote monitoring. For example, the Applied Biosystems 3730xl system supports 48-hour unattended runs with integrated robotics.

How Automation Improved Throughput, Quality, and User Experience

The integration of automation yielded several key benefits:

• Reduced hands-on labor and error risk: fewer manual steps lowers sample handling mistakes.
• Faster turnarounds: runs that once took many hours in gels are compressed into hours or less in capillaries.
• Higher consistency: automated calibration, injection, and detection ensure reproducible performance across runs.
• Scalable operations for core labs and CROs: systems with multiple capillaries support medium-scale projects while retaining high per-sample data quality.
• Ease of data management: direct digital capture enables immediate downstream processing, QC, trimming, and archiving.

Applied Biosystems, now part of Thermo Fisher, has long promoted the advantages of integrated CE systems in their user manuals. For instance, the 3730xl system is widely used for routine high-throughput Sanger and fragment analysis workflows.

Why Understanding Dideoxy Sequencing Still Matters Today

Even in the age of high-throughput, massively parallel sequencing, the logic and lessons of dideoxy (chain-termination) sequencing remain deeply relevant. Below are key reasons why mastering its principles helps you as a researcher, technologist, or project planner:

1. Ground Truth for Variant Validation

Dideoxy sequencing is still widely used to confirm variants discovered via NGS, especially in critical loci. Because of its high base accuracy, it serves as a benchmark.

When an NGS pipeline calls a novel SNP or indel, Sanger results are often used to rule out false positives.

2. Interpretation of Error Modes and Bias

Understanding how termination, dye effects, and polymerase discrimination work in Sanger helps you decode why NGS sometimes shows systematic biases (e.g. in homopolymers, GC-rich stretches).

Because many NGS platforms use terminator or reversible-terminator chemistry, the underlying concept of "stop, read, resume" echoes the dideoxy mechanism.

3. Educational and Training Value

For students or new staff in sequencing labs, dideoxy sequencing remains an accessible hands-on method to teach fundamentals of enzymatic synthesis, primer extension, and signal detection.

It forces one to consider each base individually and fosters intuition for reaction kinetics, misincorporation, and trace interpretation.

4. Best Tool for Small-Scale, High-Accuracy Tasks

When your project involves a handful of amplicons or verifying engineered constructs (e.g. plasmids, cloned inserts), dideoxy sequencing remains cost-effective and fast.

It avoids the overhead of library prep, indexing, or multiplexing complications inherent in NGS.

5. Legacy Knowledge and Method Continuity

Many existing protocols, reagents, and legacy datasets are in dideoxy format. Understanding them ensures you can contextualize historical data and integrate old and new experiments.

Projects that span decades (e.g. long-term strain monitoring, evolutionary experiments) may contain Sanger-era sequences; bridging them to NGS requires biochemical continuity.

Key Takeaways and Continuing Impact

As we wrap up, let's distill the main lessons and reflect on how dideoxy sequencing's legacy still influences today's genomics landscape.

Key Lessons at a Glance

• Core innovation: The idea of chain termination (via ddNTPs lacking a 3′-OH) remains a foundational chemical principle.
• Modern continuity: Many NGS platforms (e.g. Illumina) evolved by adapting termination logic into reversible terminator chemistry.
• Enduring strengths: High base accuracy, moderate read lengths, and ease of interpretation still make it a validation gold standard.
• Pragmatic niche use: For small-scale projects—e.g. plasmid verification or targeted variant confirmation—dideoxy sequencing remains cost-effective and efficient.
• Conceptual value: Understanding its mechanics helps researchers interpret error patterns, biases, and limitations in high-throughput methods.

Continuing Impact in Research Workflows

Even decades after its invention, dideoxy sequencing plays a strategic role in modern labs:

• Many workflows incorporate Sanger confirmation of variants detected via NGS, particularly in critical loci (the "ground truth" approach).
• Bioinformatics pipelines still must handle chromatogram analysis, peak calling, and trace inspection for Sanger data—tools like SangeR automate high-throughput Sanger analysis pipelines for variant verification workflows.
• In resource-limited or smaller-lab settings, Sanger sequencing is often the first choice due to its lower setup overhead and well-established protocols.
• In teaching and training contexts, using dideoxy sequencing helps emerging scientists internalize core principles of DNA synthesis, enzymology, and signal detection.

Final Thoughts & Why It Matters to Your Team

Dideoxy (chain-termination) sequencing may seem like "old tech" in the era of NGS and long reads, but its conceptual core and proven reliability still influence modern genomics in profound ways. Understanding this method isn't an academic exercise — it empowers you to:

• Recognise the biochemical roots of terminator chemistry in platforms like Illumina
• Diagnose sequencing artifacts and biases with deeper insight
• Choose wisely between Sanger-based confirmation and high-throughput approaches depending on project scale
• Blend validation workflows that integrate dideoxy sequencing as a quality control layer

In practice, Sanger sequencing continues to serve as a "ground truth" tool. Labs routinely use it to confirm variants flagged by NGS, validate cloning results, or assess critical bases where accuracy cannot be compromised.

The global market for Sanger sequencing services remains robust, propelled by demand for precision, regulatory validation, and niche workflows where its high base accuracy and interpretability shine.

If your research project demands flawless base calls—whether in plasmid constructs, targeted amplicons, or variant verification—dideoxy sequencing still has a rightful place in your experimental arsenal.

Next Step: Let Us Support Your Sequencing Journey

At CD Genomics, we've built our sequencing services on decades of foundational science. Here's how we can help:

• Tailored Sanger sequencing for plasmid validation, mutagenesis checks, or small-region confirmation
• Integrated NGS + validation workflows combining throughput with gold-standard accuracy
• Consultation on method selection, error diagnostics, and project design
• Rapid turnaround, expert support, and transparent data delivery

Let's discuss your project. Whether you're validating a CRISPR edit or designing a hybrid sequencing strategy, we'd be glad to help. Contact us today for a free consultation.

As you read deeper, you might want to explore:

How this classic method compares with modern high-throughput platforms — see our Sanger Sequencing vs. Next-Generation Sequencing (NGS).

How the "cycle sequencing" refinement bridges Sanger and NGS workflows — explained in What Is Cycle Sequencing.

For those intrigued by the chemistry of fluorescent tagging and signal detection, check The Chemistry Behind DNA Sequencing: Fluorescent Dyes and Signals.

FAQs — Common Questions About Dideoxy (Chain-Termination) Sequencing

Q: What is dideoxy sequencing (chain-termination sequencing)?

Dideoxy sequencing (also called Sanger sequencing) uses modified nucleotides called dideoxynucleotides (ddNTPs) that lack a 3′-hydroxyl group; when a ddNTP is incorporated into a growing DNA strand, extension terminates, producing a nested set of fragments that, when separated and detected, reveal the original template sequence.

Q: How does dideoxy sequencing differ from cycle sequencing or dye-terminator methods?

Cycle sequencing refines the Sanger method by using PCR-style cycles of denaturation, annealing, and extension so that many termination products are generated from a single template molecule; dye-terminator versions couple each ddNTP with a unique fluorescent label, allowing all four bases to be read in one reaction rather than four separate ones.

Q: What are the advantages of using ddNTPs and fluorescent labeling instead of radioactive methods?

Fluorescent labeling is safer, simpler to automate, and compatible with optical detection systems; it also allows multiplexing and efficient base calling without handling radioactivity.

Q: What limits the read length of dideoxy sequencing?

As fragment size increases, signal overlap, dye artifacts, and resolution limits in electrophoresis reduce accuracy. Typically reads of ~600–900 bases are reliable; beyond that, signal quality drops.

Q: Can dideoxy sequencing detect low-frequency variants (e.g. <10 %) in mixed samples?

Not reliably. Because Sanger sequencing reports an averaged signal from all templates, minor alleles under a certain threshold become obscured by the dominant sequence, limiting sensitivity for rare variant detection.

Q: Does dideoxy sequencing still matter in the age of NGS?

Yes. Its chemical logic underpins modern reversible termination strategies, and in practice it remains the "gold standard" for validating variants called by NGS, confirming cloning results, and providing clarity in tricky regions. Understanding its mechanism helps explain error modes and biases in high-throughput methods.

Q: How should I choose between dideoxy and NGS for my project?

Use dideoxy sequencing when your target is small (a plasmid, a single amplicon) and you need very high confidence in base calls with minimal bioinformatics overhead; use NGS when scale, depth, or multiplexing demands exceed the capacity of individual Sanger runs.

References:

1. Sanger F, Nicklen S, Coulson AR. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A. 1977 Dec;74(12):5463-7. doi: 10.1073/pnas.74.12.5463. PMID: 271968; PMCID: PMC431765.
2. Fei Chen, Mengxing Dong, Meng Ge, Lingxiang Zhu, Lufeng Ren, Guocheng Liu, Rong Mu, The History and Advances of Reversible Terminators Used in New Generations of Sequencing Technology, Genomics, Proteomics & Bioinformatics, Volume 11, Issue 1, February 2013, Pages 34–40
3. Rodriguez, R., Krishnan, Y. The chemistry of next-generation sequencing. Nat Biotechnol 41, 1709–1715 (2023).
4. Chen F, Dong M, Ge M, Zhu L, Ren L, Liu G, Mu R. The history and advances of reversible terminators used in new generations of sequencing technology. Genomics Proteomics Bioinformatics. 2013 Feb;11(1):34-40. doi: 10.1016/j.gpb.2013.01.003. Epub 2013 Jan 23. PMID: 23414612; PMCID: PMC4357665.
5. Chan, K. W., Wong, C. Y., Leung, D., Yang, X., Fok, S. F. S., Mak, P. H. S., Yao, L., Ma, W., Mao, H., Zhao, X., Liang, W., Singh, S., Barbouche, M. R., He, J. X., Jiang, L. P., Liew, W. K., Le, M. H. T., Muktiarti, D., Santos-Ocampo, F. J., Djidjik, R., … Lau, Y. L. (2022). Targeted Gene Sanger Sequencing Should Remain the First-Tier Genetic Test for Children Suspected to Have the Five Common X-Linked Inborn Errors of Immunity. Frontiers in immunology, 13, 883446.
6. Hogner, S., Lundman, E., Strand, J., Ytre-Arne, M. E., Tangeraas, T., & Stray-Pedersen, A. (2023). Newborn Genetic Screening-Still a Role for Sanger Sequencing in the Era of NGS. International journal of neonatal screening, 9(4), 67.
7. Aoki, K., Yamasaki, M., Umezono, R., Hamamoto, T., & Kamachi, Y. (2024). Systematic Comparison of Computational Tools for Sanger Sequencing-Based Genome Editing Analysis. Cells, 13(3), 261.
8. Kai Schmid, Hildegard Dohmen, Nadja Ritschel, Carmen Selignow, Jochen Zohner, Jannik Sehring, Till Acker, Daniel Amsel, SangeR: the high-throughput Sanger sequencing analysis pipeline, Bioinformatics Advances, Volume 2, Issue 1, 2022, vbac009